Annual CFO
$274.75 M
+$150.52 M+121.16%
December 31, 2023
Summary
- As of February 7, 2025, COLL annual cash flow from operations is $274.75 million, with the most recent change of +$150.52 million (+121.16%) on December 31, 2023.
- During the last 3 years, COLL annual CFO has risen by +$180.81 million (+192.47%).
- COLL annual CFO is now at all-time high.
Performance
COLL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$9.00 M
-$76.40 M-113.35%
September 30, 2024
Summary
- As of February 7, 2025, COLL quarterly cash flow from operations is -$9.00 million, with the most recent change of -$76.40 million (-113.35%) on September 30, 2024.
- Over the past year, COLL quarterly CFO has dropped by -$83.02 million (-112.16%).
- COLL quarterly CFO is now -109.02% below its all-time high of $99.72 million, reached on June 30, 2023.
Performance
COLL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$193.67 M
-$83.02 M-30.00%
September 30, 2024
Summary
- As of February 7, 2025, COLL TTM cash flow from operations is $193.67 million, with the most recent change of -$83.02 million (-30.00%) on September 30, 2024.
- Over the past year, COLL TTM CFO has dropped by -$74.06 million (-27.66%).
- COLL TTM CFO is now -37.33% below its all-time high of $309.01 million, reached on March 31, 2024.
Performance
COLL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
COLL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +121.2% | -112.2% | -27.7% |
| 3 y3 years | +192.5% | -112.2% | -27.7% |
| 5 y5 years | +62.2% | -112.2% | -27.7% |
COLL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.3% | -109.0% | +64.5% | -37.3% | +235.8% |
| 5 y | 5-year | at high | +888.9% | -109.0% | +64.5% | -37.3% | +597.1% |
| alltime | all time | at high | +466.1% | -109.0% | +64.5% | -37.3% | +322.0% |
Collegium Pharmaceutical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.00 M(-113.4%) | $193.67 M(-30.0%) |
| Jun 2024 | - | $67.40 M(+8.8%) | $276.69 M(-10.5%) |
| Mar 2024 | - | $61.94 M(-15.5%) | $309.01 M(+12.5%) |
| Dec 2023 | $274.75 M(+121.2%) | $73.34 M(-0.9%) | $274.75 M(+2.6%) |
| Sep 2023 | - | $74.02 M(-25.8%) | $267.74 M(+13.2%) |
| Jun 2023 | - | $99.72 M(+260.4%) | $236.49 M(+33.4%) |
| Mar 2023 | - | $27.67 M(-58.3%) | $177.22 M(+42.7%) |
| Dec 2022 | $124.23 M(+20.0%) | $66.33 M(+55.1%) | $124.23 M(+32.0%) |
| Sep 2022 | - | $42.77 M(+5.7%) | $94.10 M(+37.2%) |
| Jun 2022 | - | $40.45 M(-259.8%) | $68.59 M(+18.9%) |
| Mar 2022 | - | -$25.32 M(-169.9%) | $57.67 M(-44.3%) |
| Dec 2021 | $103.56 M(+10.2%) | $36.20 M(+109.8%) | $103.56 M(+15.1%) |
| Sep 2021 | - | $17.25 M(-41.6%) | $89.94 M(-15.8%) |
| Jun 2021 | - | $29.54 M(+43.6%) | $106.86 M(-11.8%) |
| Mar 2021 | - | $20.57 M(-8.9%) | $121.18 M(+29.0%) |
| Dec 2020 | $93.94 M(+238.1%) | $22.58 M(-33.9%) | $93.94 M(+8.0%) |
| Sep 2020 | - | $34.18 M(-22.1%) | $87.02 M(+47.7%) |
| Jun 2020 | - | $43.85 M(-757.6%) | $58.91 M(+98.5%) |
| Mar 2020 | - | -$6.67 M(-142.6%) | $29.68 M(+6.8%) |
| Dec 2019 | $27.78 M | $15.66 M(+158.0%) | $27.78 M(-48.9%) |
| Sep 2019 | - | $6.07 M(-58.5%) | $54.41 M(-39.7%) |
| Jun 2019 | - | $14.63 M(-270.7%) | $90.18 M(-31.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$8.57 M(-120.3%) | $131.16 M(-22.6%) |
| Dec 2018 | $169.39 M(-352.8%) | $42.29 M(+1.1%) | $169.39 M(+48.8%) |
| Sep 2018 | - | $41.83 M(-24.8%) | $113.81 M(+91.6%) |
| Jun 2018 | - | $55.60 M(+87.5%) | $59.41 M(-534.7%) |
| Mar 2018 | - | $29.66 M(-323.1%) | -$13.67 M(-79.6%) |
| Dec 2017 | -$67.02 M(-10.7%) | -$13.30 M(+5.8%) | -$67.02 M(-13.0%) |
| Sep 2017 | - | -$12.57 M(-28.1%) | -$77.01 M(-8.2%) |
| Jun 2017 | - | -$17.47 M(-26.3%) | -$83.86 M(-3.9%) |
| Mar 2017 | - | -$23.69 M(+1.7%) | -$87.22 M(+16.2%) |
| Dec 2016 | -$75.05 M(+248.0%) | -$23.29 M(+19.9%) | -$75.05 M(+23.6%) |
| Sep 2016 | - | -$19.41 M(-6.8%) | -$60.70 M(+26.9%) |
| Jun 2016 | - | -$20.84 M(+80.9%) | -$47.83 M(+52.3%) |
| Mar 2016 | - | -$11.52 M(+28.8%) | -$31.40 M(+45.6%) |
| Dec 2015 | -$21.57 M(+20.2%) | -$8.94 M(+36.8%) | -$21.57 M(+6.8%) |
| Sep 2015 | - | -$6.54 M(+48.2%) | -$20.20 M(+11.8%) |
| Jun 2015 | - | -$4.41 M(+162.4%) | -$18.07 M(+13.9%) |
| Mar 2015 | - | -$1.68 M(-77.8%) | -$15.86 M(-11.6%) |
| Dec 2014 | -$17.95 M(+8.6%) | -$7.57 M(+71.7%) | -$17.95 M(+72.9%) |
| Sep 2014 | - | -$4.41 M(+100.3%) | -$10.38 M(+73.8%) |
| Jun 2014 | - | -$2.20 M(-41.6%) | -$5.97 M(+58.4%) |
| Mar 2014 | - | -$3.77 M | -$3.77 M |
| Dec 2013 | -$16.53 M | - | - |
FAQ
- What is Collegium Pharmaceutical annual cash flow from operations?
- What is the all time high annual CFO for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual CFO year-on-year change?
- What is Collegium Pharmaceutical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly CFO year-on-year change?
- What is Collegium Pharmaceutical TTM cash flow from operations?
- What is the all time high TTM CFO for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical TTM CFO year-on-year change?
What is Collegium Pharmaceutical annual cash flow from operations?
The current annual CFO of COLL is $274.75 M
What is the all time high annual CFO for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual cash flow from operations is $274.75 M
What is Collegium Pharmaceutical annual CFO year-on-year change?
Over the past year, COLL annual cash flow from operations has changed by +$150.52 M (+121.16%)
What is Collegium Pharmaceutical quarterly cash flow from operations?
The current quarterly CFO of COLL is -$9.00 M
What is the all time high quarterly CFO for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly cash flow from operations is $99.72 M
What is Collegium Pharmaceutical quarterly CFO year-on-year change?
Over the past year, COLL quarterly cash flow from operations has changed by -$83.02 M (-112.16%)
What is Collegium Pharmaceutical TTM cash flow from operations?
The current TTM CFO of COLL is $193.67 M
What is the all time high TTM CFO for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high TTM cash flow from operations is $309.01 M
What is Collegium Pharmaceutical TTM CFO year-on-year change?
Over the past year, COLL TTM cash flow from operations has changed by -$74.06 M (-27.66%)